Answers are grounded in this paper and cite their sources.
Multidrug-resistant tuberculosis (MR-TB) remains a major global public health concern, particularly among women of reproductive age. The management of MR-TB during pregnancy is particularly challenging, owing to the limited clinical experience and evidence regarding the safety and efficienty of second-line antituberculosis drugs in this population. We report two cases of MR-TB occurring during pregnancy. Both patients were closely monitored throughout pregnancy and postpartum, and at three months of follow-up, both mothers and their infants were clinically well, with no significant complications reported. These cases highlight the complexities involved in managing MR-TB during pregnancy and underscore the need for individualized therapeutic strategies and multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
C et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: